性 狀：本品為膠囊劑。內容物為棕色的粉末。

產品簡介：本產品採用100%無污染純天然栽培的全赤靈芝孢子，經第四代的微科技工藝把靈芝孢子幾丁質外殼剝除微研成次納米狀態，比較普通破壁孢子粉更容易被人體吸收，有效率達93%以上，本品含有三萜類、多糖、氨基酸多肽、腺苷和有機鍺、生物鹼等多種活性物質，對提高人體免疫力有顯效。

功 效：本產品具有免疫調節的保健功能，可作保健食品長期服用。
注意事項：保存於陰涼乾燥處，避免兒童觸及。心臟病及腦中風患者、孕婦及哺乳期婦女禁用。如有必要，請諮詢相關醫師服用。使用效果有個體差異。

根據美國醫藥衛生條例，以上的中醫藥理並未經美國食品和醫藥局的正式評估，因此本品不宜作藥用註解。根據香港標準及檢定中心測試結果，全赤靈芝微研孢子湯之樣本符合香港特別行政區政府-衛生署所制定之[中成藥註冊]安全性資料技術指引(2004)之中成藥重金屬或有毒元素，農藥殘留及微生物限度(含原藥材-膠囊劑)

建議用量：口服一次2-4粒  一日2次。

規    格：每粒0.25克。

儲    藏：密封，置陰涼處。

包    裝：鋁塑包裝  

12粒/盒(輕便裝)  12粒/盒X5(禮品裝)。

Character: It is in the form of capsule with powder in brown color inside.

Product introduction: This product uses the fourth generation of micro technique, which breaks the chitin of the entire brown ganoderma lucidum spore in a nanometer condition after its 100% non-polluted and pure natural cultivation. The absorption efficiency for human body of this product is above 93% compared with the ordinary wall-broken spore powder. This product contains many kinds of active substance of triterpenoids, polysaccharide, nucleosides, amino acids, enzymes, trace elements, organic Ge and alkaloids, and etc, to enhance immunity for human body.

Efficiency: The product can strengthen and accommodate immune function of human body. It can be used for a long period of time.

Warning: Keep out of the reach of children. Effects may vary. Consult a doctor if you suffer of cardiopathy or apoplexy, or if nursing or pregnant. Store in a cool and dry place.

These statements have not been evaluated by the Food and Drug Administration. The product is not intended to diagnose, treat, cure or prevent any disease. According to test results from the Hong Kong Standards and Testing Centre Ltd., the sample of Ganoderma Lucidum Herbal Supplement is complied with the Heavy Metals or Toxic Elements, Residual Pesticides and Microbial Limit (With crude drug powder –capsules) stipulated in the Technical Guidelines in Product Safety documents for Registration of Proprietary Chinese Medicine (2004), sanctioned by the Department of Health of the Government of the HKSAR.